Chromium (VI)-induced cytotoxicity to osteoblast-derived cells

Toxicology in Vitro

Volumn 13, Issue 6, 1999, Pages 879-887

  Ning, J ^a   Grant, M H ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Chromium (VI) reduction; Chromium (VI) toxicity; Osteoblasts

Indexed keywords

ALKALINE PHOSPHATASE; ANTIOXIDANT; ASCORBIC ACID; BUTHIONINE SULFOXIMINE; CHROMIUM; DICOUMAROL; GLUTATHIONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); RIBOFLAVIN;

ANIMAL CELL; ARTICLE; CELL FREE SYSTEM; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; NONHUMAN; OSTEOBLAST; PROTEIN CONTENT; RAT; TOXICOKINETICS;

EID: 0032804136     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2333(99)00075-2     Document Type: Article

References (46)

1. 51Cr-chromate by human erythrocytes - a role for glutathione. Acta Pharmacologia Toxicologia. 50:1982;310-315.
2. Aiyar J., Berkovits H.J., Floyd R.A., Wetterhahn K.E. Reaction of chromium(VI) with hydrogen peroxide in the presence of glutathione: reactive intermediates and resulting DNA damage. Chemical Research in Toxicology. 3:1990;595-603.
3. Berridge M.V., Tan A.S. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT): subcellular localization, substrate dependence and involvement of mitochondrial electron transport in MTT reduction. Archives of Biochemistry and Biophysics. 303:1993;474-482.
4. Brien W.W., Salvati E.A., Healey J.A., Bansal M., Ghelman B., Betts F. Osteogenic sarcoma arising in the area of a total hip replacement. Journal of Bone and Joint Surgery. 72A:1990;1097-1099.
5. Coogan T.P., Mots J., Snyder C.A., Squibb K.S., Costa M. Differential DNA-protein crosslinking in lymphocytes and liver following chronic drinking water exposure of rat to potassium chromate. Toxicology and Applied Pharmacology. 109:1991;60-72.
6. Coundray C., Faure P., Rachidi S., Jeunet A., Richard M.J., Roussel A.M., Favier A. Hydroxyl radical formation and lipid peroxidation enhancement by chromium: in vitro study. Biological Trace Element Research. 32:1992;161-170.
7. Cupo D. Y. and Wetterhahn K. E. (1985) Modification of chromium (VI) induced DNA damage by glutathione and cytochromes P450 in chicken embryo hepatocytes. Proceedings of the National Academy of Sciences of the U.S.A. 82, 6755-6759.
8. Debetto P., Arslan P., Antoli M., Luciani S. Uptake of chromate by rat thymocytes and role of glutathione in its cytoplasmic reduction. Xenobiotica. 18:1988;657-664.
9. De Flora S., Morelli A., Basso C., Romano M., Serra D., De Flora A. Prominent role of DT-diaphorase as a cellular mechanism reducing chromium (VI) and reverting its mutagenicity. Cancer Research. 45:1985;3188-3196.
10. Dobbs H. S. and Minski M. J. (1982) Metal ion release after total hip replacement. In Biomaterials, ed. G. D. Winter, D. F. Gibbons and H. Plenk, pp. 255-263. John Wiley & Sons, London.
11. Galante J.O., Lemons J., Spector M., Wilson P.D., Wright T.M. The biological effects of implant materials. Journal of Orthopaedic Research. 9:1991;760-775.
12. Granchi D., Cenni E., Ciapetti G., Savarino L., Stea S., Gamberini S., Gori A., Pizzoferrato A. Cell death induced by metal ions: necrosis or apoptosis? Journal of Materials Science-Materials in Medicine. 9:1998;31-37.
13. Grant M.H., Nugent C., Bertrand R. Studies on nickel-induced inhibition of fibroblast growth. Toxicology in Vitro. 8:1994;191-195.
14. Gualtieri G., Gualtieri I., Gagliardi S., Pazzaglia U. E., Minoia C. and Ceciliani L. (1987) Metal ion levels in organic fluids of patients with Co-Cr-Mo alloy hip prostheses. In Biomaterials and Clinical Applications, ed. A. Pizzoferrato, P. G. Marchetti, A. Ravaglioli and A. J. C. Lee, pp. 729-734. Elsevier, Amsterdam.
15. Hino Y., Yoon S.B., Kajiyama K., Kagiyama A., Ogura R. Effect of riboflavin-butyrate on cardiac glutathione reductase affected by Adriamycin. Journal of Nutrition Science and Vitaminology. 31:1985;139-145.
16. Hissin P.J., Hilf R. A fluorimetric method for the determination of oxidised and reduced glutathione in tissue. Analytical Biochemistry. 74:1976;214-226.
17. Jacobs J.J., Rosenbaum D.H., Hay R.M., Gitelis S., Black J. Early sarcomatous degeneration near a cementless hip replacement. Journal of Bone and Joint Surgery. 74B:1992;740-744.
18. Korallus U., Harzdorf C., Lewalter J. Experimental bases for ascorbic acid therapy of poisoning by hexavalent chromium compounds. Industrial Archives of Occupational and Environmental Health. 53:1984;247-256.
19. Kortenkamp A., Casadevall M., Faux S.P., Jenner A., Shayer R.O.J., Woodbridge N., O'Brien P. A role for molecular oxygen in the formation of DNA damage during the reduction of the carcinogen chromium (VI) by glutathione. Archives of Biochemistry and Biophysics. 329:1996;199-207.
20. Kreibich D.N., Moran C.G., Delves H.T., Owen T.D., Pinder I. Systemic release of cobalt and chromium after uncemented total hip replacement. Journal of Bone and Joint Surgery. 78B:1996;18-21.
21. Langard S. (1983) The carcinogenicity of chromium compounds in man and animals. In Chromium: Metabolism and Toxicity, ed. D. Burrows, pp. 13-30. CRC Press, Boca Raton, FL.
22. Lind C., Hojeberg B. Biospecific absorption of hepatic DT-Diaphorase on immobilised dicoumarol. Archives of Biochemistry and Biophysics. 270:1981;217-224.
23. Liu K.J., Shi X., Dalal N.S. Synthesis of CR(VI)-GSH, its identification and its free hydroxyl radical generation: a model compound for Cr(VI) carcinogenicity. Biochemical and Biophysical Research Communications. 235:1997;54-58.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry. 193:1951;265-275.
25. McKay G.C., Macnair R., MacDonald C., Grant M.H. Interactions of orthopaedic metals with an immortalized rat osteoblast cell line. Biomaterials. 17:1996;1339-1344.
26. Macnair R., Rodgers E.H., Macdonald C., Wykman A., Goldie I., Grant M.H. The response of primary rat and human osteoblasts and an immortalized rat osteoblast cell line to orthopaedic materials: Comparative sensitivity of several toxicity indices. Journal of Materials Science-Materials in Medicine. 8:1997;105-111.
27. Macnair R., Wilkinson R., MacDonald C., Goldie I., Jones D.B., Grant M.H. Application of confocal laser scanning microscopy to cytocompatibility testing of potential orthopaedic materials in immortalised osteoblast-like cell lines. Cells and Materials. 6:1996;71-78.
28. Marshall N.J., Goodwin C.J., Holt S.J. A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Regulation. 5:1995;69-84.
29. Martin A., Bauer T.W., Manley M.T., Marks K.E. Osteosarcoma at the site of total hip replacement. Journal of Bone and Joint Surgery. 70A:1988;1561-1567.
30. Morrison C., Macnair R., MacDonald C., Wykman A., Goldie I., Grant M.H. In vitro biocompatibility testing of polymers for orthopaedic implants using cultured fibroblasts and osteoblasts. Biomaterials. 16:1995;987-992.
31. Pinto J., Raiczyk G.B., Huang Y.P., Rivlin R.S. New approaches to the possible prevention of side effects of chemotherapy by nutrition. Cancer. 58:1986;1911-1914.
32. Popper H.H., Grygar E., Ingolic E., Wawschinek O. Cytotoxicity of chromium III and VI compounds. I. In vitro studies using different cell culture systems. Inhalation Toxicology. 5:1993;345-369.
33. Rodney P.F., Robert J.J., Lay P.A., Dixon N.E., Raker R.S.U., Bonin A.M. Chromium(V)-induced cleavage of DNA: are chromium(V) complexes the active carcinogens in chromium(VI)-induced cancer? Chemical Research in Toxicology. 2:1989;227-229.
34. Ross D. Mechanistic toxicology: A radical perspective. Journal of Pharmacy and Pharmacology. 41:1989;505-511.
35. Shi X.L., Dalal N.S. Chromium (V) and hydroxyl radical formation during the glutathione reductase-catalysed reduction of chromium (VI). Biochemical and Biophysical Research Communications. 163:1989;627-634.
36. Standeven A.M., Wetterhahn K.E. Chromium(VI) toxicity: uptake, reduction and DNA damage. Journal of the American College of Toxicology. 8:1989;1275-1283.
37. Sugiyama M. Role of physiological antioxidants in chromium (VI)-induced cellular injury. Free Radical Biology and Medicine. 12:1992;397-407.
38. Sugiyama M., Ando A., Nakao K., Ueta H., Hidaka T., Ogura R. Influence of vitamin B2 on formation of chromium (V), alkali-labile sites, and lethality of sodium chromate (VI) in Chinese hamster V-79 cells. Cancer Research. 49:1989;6180-6184.
39. Sugiyama M., Ando A., Ogura R. Effect of vitamin E on survival, glutathione reductase and formation of chromium (V) in Chinese hamster V-79 cells treated with sodium chromate (VI). Carcinogenesis. 10:1989;737-741.
40. 4 in synchronous and asynchronous cultured mammalian cells. Molecular Pharmacology. 29:1986;606-613.
41. Sugiyama M., Tsuzuki K., Ogura R. Effect of ascorbic acid on DNA damage, cytotoxicity, glutathione reductase, and formation of paramagnetic chromium in Chinese hamster V-79 cells treated with sodium chromate (VI). Journal of Cell Biology. 266:1991;3383-3386.
42. Sunderman F.W., Hopfer S.M., Swift T., Rezuke W.N., Ziebka L., Highman P., Edwards B., Folik M., Gossling H.R. Cobalt, chromium and nickel concentrations in body fluids with porous-coated knee or hip prostheses. Journal of Orthopaedic Research. 7:1989;307-315.
43. Suzuki Y., Fukuda K. Reduction of hexavalent chromium by ascorbic acid and glutathione with special reference to the rat lung. Archives of Toxicology. 64:1990;169-176.
44. Vistica D.T., Skehan P., Scudiero D., Monks A., Pittman A., Boyd M.R. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Research. 51:1991;2515-2520.
45. Ward J.J., Thornburn D.D., Lemons J.E., Dunham W.K. Metal-induced sarcoma. A case report and literature review. Clinical Orthopaedics and Related Research. 252:1990;299-306.
46. 51Cr (VI) by red blood cells of man and rat. Archives of Toxicology. 57:1985;31-34.